BRISTOL MYERS SQUIBB CO Overview
Industry: -
Sector: -
Read MoreMavefund brings filings, fundamentals, valuation, price history and news for BRISTOL MYERS SQUIBB CO into one research view. The sections below show what strengthens or weakens the research case.
Score
Reported Results
What the company reported, with filing details kept small.
Quarterly result summary
EPS was $6.05 (reported).
What changed
- EPS reported to $6.05.
Guidance / outlook
No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.
Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.
Other recent earnings materials
Prediction-grade evidence
Recent News
Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.
Bristol Myers Squibb (BMY) Stock May Be 46% Undervalued As FDA Approval Lands
Headline from Yahoo Finance: Bristol Myers Squibb (BMY) Stock May Be 46% Undervalued As FDA Approval Lands.
Bristol Myers Squibb (BMY) Wins FDA Approval, Is The Stock Fully Priced?
Headline from Yahoo Finance: Bristol Myers Squibb (BMY) Wins FDA Approval, Is The Stock Fully Priced?
US FDA approves Bristol Myers' blood cancer treatment
Headline from Reuters: US FDA approves Bristol Myers' blood cancer treatment.
US FDA approves Bristol Myers' blood cancer treatment
Headline from Reuters: US FDA approves Bristol Myers' blood cancer treatment.
AstraZeneca PLC (AZN) vs. Bristol-Myers Squibb Company (BMY): Wall Street Doesn’t Buy This Merger Talk
Headline from Yahoo Finance: AstraZeneca PLC (AZN) vs. Bristol-Myers Squibb Company (BMY): Wall Street Doesn’t Buy This Merger Talk.
Bristol-Myers Squibb Q1 2026 Earnings Call Transcript
Headline from Fortune: Bristol-Myers Squibb Q1 2026 Earnings Call Transcript.
Earnings Per Share
Return on Equity
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
ROE
Company —
Sector Median —
Metric chart temporarily unavailable.
Net Margin
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Net Margin
Company —
Sector Median —
Metric chart temporarily unavailable.
Leverage
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Leverage
Company —
Sector Median —
Metric chart temporarily unavailable.
Financial Statements
Company-reported SEC EDGAR facts organized into the three core statements.
Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.